1. Home
  2. CPSS vs NKTX Comparison

CPSS vs NKTX Comparison

Compare CPSS & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$9.11

Market Cap

208.7M

Sector

Finance

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.29

Market Cap

198.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
NKTX
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.7M
198.2M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
CPSS
NKTX
Price
$9.11
$2.29
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.33
AVG Volume (30 Days)
23.8K
790.6K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
11.88
EPS
0.24
N/A
Revenue
$434,470,000.00
N/A
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$39.29
N/A
Revenue Growth
10.41
N/A
52 Week Low
$6.67
$1.70
52 Week High
$10.49
$3.72

Technical Indicators

Market Signals
Indicator
CPSS
NKTX
Relative Strength Index (RSI) 51.19 34.58
Support Level $9.40 $1.84
Resistance Level $9.53 $2.32
Average True Range (ATR) 0.31 0.24
MACD 0.01 -0.08
Stochastic Oscillator 67.74 4.36

Price Performance

Historical Comparison
CPSS
NKTX

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: